:::

詳目顯示

回上一頁
題名:從C型肝炎病毒感染細胞之凋亡談現行治療之免疫機轉
書刊名:弘光學報
作者:黃俐綾謝東呈 引用關係
作者(外文):Huang, Li-lingShieh, Dong-chen
出版日期:2008
卷期:53
頁次:頁95-108
主題關鍵詞:C型肝炎病毒干擾素凋亡RibavirinHepatitis C virusInterferonApoptosis
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:3
  • 點閱點閱:26
期刊論文
1.洪業晃、陳奕儒、陳明豐、楊基滐、朱彥璋(20061200)。甘草甜素對慢性C型肝炎血清生化值的臨床觀察。中西整合醫學雜誌,8(1),27-31。  延伸查詢new window
2.胡志棠(20010500)。C型肝炎病毒與細胞交通。當代醫學,28(5)=331,73-79。  延伸查詢new window
3.劉俊人、高嘉宏(20070900)。B型肝炎病毒基因型與病毒量之臨床意義。臺灣醫學,11(5),485-495。  延伸查詢new window
4.高嘉宏、陳定信(19980600)。C型肝炎在臺灣。中華公共衛生雜誌,17(3),191-197。new window  延伸查詢new window
5.郭佑啟(20020000)。C型肝炎。中化藥訊,53,17-21。  延伸查詢new window
6.章振旺、朱正心、張文熊、陳逸洲(20061200)。C型肝炎相關之腎病變。內科學誌,17(6),259-263。  延伸查詢new window
7.謝忠憲、朱宗信(20010500)。C型肝炎病毒相關的腎臟病變。臺灣醫學,5(3),352-356。  延伸查詢new window
8.Balachandran, S.、Roberts, P. C.、Brown, L. E.(2000)。Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection。Immunity,13,129-141。  new window
9.Bantel, H.、Lugering, A.、Poremba, C.(2001)。Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection。Hepatology,34,758-767。  new window
10.Barber, G. N.(2001)。Host defense, viruses and apoptosis。Cell Death Differ,8,113-126。  new window
11.Barth, H.、Liang, T. J.、Baumert, T. F.(2006)。Hepatitis C virus entry: molecular biology and clinical implications。Hepatology,44,527-535。  new window
12.Bowie, A. G.、Fitzgerald, K. A.(2007)。RIG-I: trying to discriminate between self and nonself RNA。Trends Immunol,28,147-150。  new window
13.Brenner, C.、Grimm, S.(2006)。The permeability transition pore complex in cancer cell death。Oncogene,25,4744-4756。  new window
14.Chiou, H .L.、Hsieh, Y. S.、Hsieh, M. R.、Chen, T. Y.(2006)。HCV E2 may induce apoptosis of Huh-7 cells via a mitochondrial-related caspase pathway。Biochem Biophys Res Commun,345,453-458。  new window
15.Der, S. D.、Yang, Y. L.、Weissmann, C.、Williams, B. R.(1997)。A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis。Proc Natl Acad Sci USA,94,3279-3283。  new window
16.Erickson, A. L.、Kimura, Y.、Igarashi, S.(2001)。The outcome of hepatitis C virus infection is predicted by escape mutation in epitopes targeted by cytotoxic T lymphocytes。Immunity,15,883-895。  new window
17.Faouzi, S.、Burckhardt, B. E.、Hanson, J. C.、Campe, C. B.、Schrum, L. W.、Maher, J. J.(2001)。Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3- dependent pathway。J. Biol. Chem,276,4977-4982。  new window
18.Fischer, R.、Schmitt, M.、Bode, J. G.、Haussinger, D.(2001)。Expression of the peripheral-type benzodiazepine receptor and apoptosis induction in hepatic stellate cells。Gastroenterology,120,1212-1226。  new window
19.Fluda, S.、Debatin, K. M.(2002)。IFN gamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway。Oncogene,21,2295-2308。  new window
20.Bantel, H.、Schulze-Osthoff, K.(2003)。Apoptosis in hepatitis C virus infection。Cell death and Differentiation,10,48-58。  new window
21.Lee, S. K.、Park, S. O.、Joe, C. O.、Kim, Y. S.(2007)。Interaction of HCV core protein with 14-3-3 epsilon protein releases Bax to activate apoptosis。Biochem Biophys Res Commun,352,756-762。  new window
22.Machida, K.、Cheng, K. T.、Lai, C. K.、Jeng, K. S.、Sung, V. M.、Lai, M. M.(2006)。Hepatitis C virus triggers mitochondria permeability transition with production of reactive oxygen species, leading to DNA damage and STAT3 activation。Virol,80,7199-7207。  new window
23.Seeff, L. B.(2002)。Natural history of chronic hepatitis C。Hepatology,36,35-46。  new window
24.Fischer, R.、Baumert, T.、Blum, H. E.(2007)。Hepatitis C virus infection and apoptosis。World J Gastroenterol,13(36),4865-4872。  new window
25.Ferenci, P.、Fried, M. W.、Schiffman, M. L.、Smith, C. I.、Marinos, G.、Goncales, F. L.(2005)。Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirin。Journal of Hepatology,43,425-433。  new window
26.Stark, G. R.、Kerr, I. M.、Williams, B. R.、Silverman, R. H.、Schreiber, R. D.(1998)。How cells respond to interferons。Annu Rev Biochem,67,227-264。  new window
27.Yoneyama, M.、Fujita, T.(2007)。Function of RIG-I-like receptors in antiviral innate immunity。J Biol Chem,282,15315-15318。  new window
28.Strater, J.、Walczak, H.、Pukrop, T.(2002)。TRAIL and its receptors in the colonic epithelium: a putative role in the defense of viral infections。Gastroenterology,122,659-666。  new window
29.Zhang, P.、Samuel, C. E.(2007)。Protein kinase PKR plays a stimulus and virus-dependent role in apoptotic death and virus multiplication in human cells。J Virol,81,8192-8200。  new window
30.李燕鳴(20040200)。基層醫療中C型肝炎之諮詢與防制。基層醫學,19(2),41-46。  延伸查詢new window
31.許景盛、高嘉宏(20070900)。病毒性肝炎與代謝症候群。臺灣醫學,11(5),518-529。  延伸查詢new window
32.曾光毅、曾嵩智、林佩璇(20040300)。現階段C型肝炎的預防與治療。基層醫學,19(3),61-66。  延伸查詢new window
33.趙玉雯、吳義勇(20020200)。C型肝炎病毒感染于末期腎病接受透析病患及腎臟移植病患之近況趨勢。腎臟與透析,14(1),19-25。  延伸查詢new window
34.蔡順隆(20030600)。B型與C型肝炎的免疫致病機轉。當代醫學,30(6)=356,437-448。  延伸查詢new window
35.Bartenschlager, R.(2006)。Hepatitis C virus molecular clones: from cDNA to infectious virus particles in cell culture。Curr Opin Microbiol,9,416-422。  new window
36.Eichhorst, S. T.(2005)。Modulation of apoptosis as a target for liver disease。Expert Opin Ther Targets,9,83-99。  new window
37.Deveraux, Q. L.、Reed, J. C.(1999)。IAP family proteins- suppressors of apoptosis。Genes Dev,13,239-252。  new window
38.Weber, F.(2007)。Interaction of hepatitis C virus with the type I interferon system。World J Gastroenterol,13(36),4818-4823。  new window
39.Gil, J.、Esteban, M.(2000)。Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action。Apoptosis,5,107-114。  new window
40.Hiscott, J.(2007)。Triggering the innate antiviral response through IRF-3 activation。J Biol Chem,282,15325-15329。  new window
41.Hopwood, M.、Treloar, C.(2005)。The experience of interferon-based treatments for hepatitis C infection。Qual Health Res,15(5),635-646。  new window
42.Kubo, M.、Hanada, T.、Yoshimura, A.(2003)。Suppressors of cytokine signaling and immunity。Nat Immunol,4,1169-1176。  new window
43.Kumar, S.(2007)。Caspase function in programmed cell death。Cell Death Differ,14,32-43。  new window
44.Levy, D. E.、Darnell, J. E.(2002)。Stats: transcriptional control and biological impact。Nat Rev Mol Cell Biol,3,651-662。  new window
45.Lindenbach, B. D.、Evans, M. J.、Syder, A. J.(2005)。Complete replication of hepatitis C virus in cell culture。Science,309,623-626。  new window
46.Meylan, E.、Curran, J.、Hofmann, K.(2005)。Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus。Nature,437,1167-1172。  new window
47.Samuel, C. E.(2001)。Antiviral actions of interferons。Clin Microbiol Rev,14,778-809。  new window
48.Schaefer, U.、Voloshanenko, O.、Willen, D.、Walczak, H.(2007)。TRAIL: a multifunctional cytokine。Front Biosci,12,3813-3824。  new window
49.Shuai, K.、Liu, B.(2005)。Regulation of geneactivation pathway by PIAS proteins in the immune system。Nat Rev Immurol,5,593-605。  new window
50.劉俊人、賴明陽(19981100)。慢性C型肝炎之治療。臺灣醫學,2(6),661-667。  延伸查詢new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
QR Code
QRCODE